Association between statins given in hospital and mortality in pneumonia patients

Journal of General Internal Medicine

Volumn 27, Issue 3, 2012, Pages 280-286

  Rothberg, Michael B ^a,b   Bigelow, Carol ^c   Pekow, Penelope S ^a,c   Lindenauer, Peter K ^a,b  

^a BAYSTATE MEDICAL CENTER   (United States)

^b TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF MASSACHUSETTS   (United States)

Author keywords

Evidence based medicine; Health services research; Hospital medicine

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; CEPHALOSPORIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; EZETIMIBE; FIBRIC ACID DERIVATIVE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; NICOTINIC ACID; PENICILLIN G; RESIN; THIAMINE;

AFRICAN AMERICAN; AGED; ANEMIA; ANTIBIOTIC THERAPY; ARTICLE; ASSISTED VENTILATION; BACTERIAL INFECTION; CHRONIC LUNG DISEASE; CIGARETTE SMOKING; COMMUNITY ACQUIRED PNEUMONIA; COMORBIDITY; CORRELATIONAL STUDY; DEPRESSION; DIABETES MELLITUS; DIET SUPPLEMENTATION; DISEASE SEVERITY; EUROPEAN AMERICAN; FEMALE; GASTROSTOMY; GEOGRAPHY; HISPANIC; HOSPITAL ADMISSION; HOSPITAL BED CAPACITY; HOSPITAL DISCHARGE; HOSPITAL READMISSION; HUMAN; HYPERTENSION; HYPOTHYROIDISM; INFLUENZA; INTENSIVE CARE UNIT; ISCHEMIC HEART DISEASE; JEJUNOSTOMY TUBE; KIDNEY FAILURE; MAJOR CLINICAL STUDY; MALE; MORTALITY; NEUROLOGIC DISEASE; OBESITY; OBSERVATIONAL STUDY; PERIPHERAL VASCULAR DISEASE; PNEUMONIA; RACE; RESPIRATORY FAILURE; SEPTICEMIA; SOLID TUMOR; STAPHYLOCOCCUS INFECTION; TEACHING HOSPITAL; TOTAL PARENTERAL NUTRITION; TREATMENT OUTCOME; URINARY CATHETER;

AGED; FEMALE; FOLLOW-UP STUDIES; HOSPITAL MORTALITY; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; INPATIENTS; MALE; PNEUMONIA; RETROSPECTIVE STUDIES; SURVIVAL RATE; TREATMENT OUTCOME; UNITED STATES;

EID: 84862543937     PISSN: 08848734     EISSN: 15251497     Source Type: Journal    
DOI: 10.1007/s11606-011-1826-2     Document Type: Article

References (26)

1. Minino AM, Xu J, Kochanek KD, Tejada-Vera B. Death in the United States, 2007. NCHS Data Brief 2009:1-8.
2. Marrie TJ. Pneumococcal pneumonia: epidemiology and clinical features. Semin Respir Infect 1999;14:227-36.
3. Marshall JC. Sepsis: current status, future prospects. Curr Opin Crit Care 2004;10:250-64.
4. Jain MK, Ridker PM. Anti-inflammatory effects of statins: clinical evidence and basic mechanisms. Nat Rev Drug Discov 2005;4:977-87.
5. Novack V, Eisinger M, Frenkel A et al. The effects of statin therapy on inflammatory cytokines in patients with bacterial infections: a randomized double-blind placebo controlled clinical trial. Intensive Care Med 2009;35:1255-60 Epub 2009 Feb 11.
6. Ando H, Takamura T, Ota T, Nagai Y, Kobayashi K. Cerivastatin improves survival of mice with lipopolysaccharide-induced sepsis. J Pharmacol Exp Ther 2000;294:1043-6.
7. Merx MW, Liehn EA, Graf J et al. Statin treatment after onset of sepsis in a murine model improves survival HMG-CoA reductase inhibitor simvastatin profoundly improves survival in a murine model of sepsis. Circulation 2005;112:117-24.
8. Merx MW, Liehn EA, Janssens U et al. HMG-CoA reductase inhibitor simvastatin profoundly improves survival in a murine model of sepsis. Circulation 2004;109:2560-5. Epub 2004 May 3.
9. Yasuda H, Yuen PS, Hu X, Zhou H, Star RA. Simvastatin improves sepsis-induced mortality and acute kidney injury via renal vascular effects. Kidney Int 2006;69:1535-42.
10. Tleyjeh IM, Kashour T, Hakim FA et al. Statins for the prevention and treatment of infections: a systematic review and meta-analysis. Arch Intern Med 2009;169:1658-67.
11. Brookhart MA, Patrick AR, Dormuth C et al. Adherence to lipidlowering therapy and the use of preventive health services: an investigation of the healthy user effect. Am J Epidemiol 2007;166:348-54.
12. Majumdar SR, McAlister FA, Eurich DT, Padwal RS, Marrie TJ. Statins and outcomes in patients admitted to hospital with community acquired pneumonia: population based prospective cohort study. BMJ 2006;333:999.
13. Donnino MW, Cocchi MN, Howell M et al. Statin therapy is associated with decreased mortality in patients with infection. Acad Emerg Med 2009;16:230-4.
14. Dobesh PP, Klepser DG, McGuire TR, Morgan CW, Olsen KM. Reduction in mortality associated with statin therapy in patients with severe sepsis. Pharmacotherapy 2009;29:621-30.
15. Kruger P, Fitzsimmons K, Cook D, Jones M, Nimmo G. Statin therapy is associated with fewer deaths in patients with bacteraemia. Intensive Care Med 2006;32:75-9.
16. Centers for Medicare and Medicaid Services. ICD-10-CM Official Guidelines for Coding and Reporting. 2010; available at http://www.cms.gov/ICD10/ Downloads/7-Guidelines10cm2010.pdf. Accessed on February 12, 2011.
17. Elixhauser A, Steiner C, Harris DR, Coffey RM. Comorbidity measures for use with administrative data. Med Care 1998;36:8-27.
18. Parsons L. Reducing Bias in a Propensity Score Matched-Pair Sample Using Greedy Matching Techniques. Proceedings of the Twenty-sixth Annual SAS Users Group International Conference. Cary, NC: SAS Institute; 2001.
19. Mortensen EM, Restrepo MI, Anzueto A, Pugh J. The effect of prior statin use on 30-day mortality for patients hospitalized with communityacquired pneumonia. Respir Res 2005;6:82.
20. Schlienger RG, Fedson DS, Jick SS, Jick H, Meier CR. Statins and the risk of pneumonia: a population-based, nested case-control study. Pharmacotherapy 2007;27:325-32.
21. ThomsenRW, Riis A, KornumJB, Christensen S, Johnsen SP, Sorensen HT. Preadmission use of statins and outcomes after hospitalization with pneumonia: population-based cohort study of 29,900 patients. Arch Intern Med 2008;168:2081-7.
22. Dublin S, Jackson ML, Nelson JC, Weiss NS, Larson EB, Jackson LA. Statin use and risk of community acquired pneumonia in older people: population based case-control study. BMJ 2009;338:b2137. doi:10.1136/bmj.b2137.
23. Kwong JC, Li P, Redelmeier DA. Influenza morbidity and mortality in elderly patients receiving statins: a cohort study. PLoS One 2009;4: e8087.
24. Fonarow GC, Wright RS, Spencer FA et al. Effect of statin use within the first 24 hours of admission for acute myocardial infarction on early morbidity and mortality. Am J Cardiol 2005;96:611-6.
25. Levesque LE, Hanley JA, Kezouh A, Suissa S. Problem of immortal time bias in cohort studies: example using statins for preventing progression of diabetes. Bmj 2010;340:b5087.
26. Fedson DS. Pandemic influenza: a potential role for statins in treatment and prophylaxis. Clin Infect Dis 2006;43:199-205.